| Editorial |
|
|
|
| Review Article |
|
|
|
| Special Issues |
|
|
|
The Korean College of Rheumatology: 40 Years of Public Health Influence |
| Jisoo Lee, M.D., Ph.D., Yoon-Kyoung Sung, M.D., Ph.D., M.P.H., Myeung-Su Lee, M.D., Ph.D., Han Joo Baek, M.D., Ph.D. |
|
J Rheum Dis 2022; 29(2): 75-78
|
|
|
| Original Articles |
|
Assessment on Treatments With Conventional Synthetic Disease-modifying Drugs Before Initiating Biologics in Patients With Rheumatoid Arthritis in Korea: A Population-based Study |
| Min Jung Kim, M.D., Eun Hye Park, M.D., Ph.D., Anna Shin, Ph.D., You-Jung Ha, M.D., Yun Jong Lee, M.D., Ph.D., Eun Bong Lee, M.D., Ph.D., Han Joo Baek, M.D., Ph.D., Eun Ha Kang, M.D., Ph.D., M.P.H. |
|
J Rheum Dis 2022; 29(2): 79-88
|
|
|
Evaluation of Serum Matrix Metalloproteinase-3 as an Objective Indicator for the Disease Activity in Rheumatoid Arthritis Patients Treated With Methotrexate Versus Tocilizumab: 24-week Results From a Prospective Randomized Controlled Study |
| Jina Yeo, M.D., Han Joo Baek, M.D., Ph.D., Yeong Wook Song, M.D., Ph.D., Eun Young Lee, M.D., Ph.D. |
|
J Rheum Dis 2022; 29(2): 89-97
|
|
|
Time-integrated Cumulative Parameters Predictive of Radiographic Progression of Rheumatoid Arthritis: Real-world Data From a Prospective Single-center Cohort |
| Youngjae Park, M.D., Mei-Ling Li, M.D., Ji-Won Kim, M.D., Ph.D., Jung Hee Koh, M.D., Ph.D., Yune-Jung Park, M.D., Ph.D., Wan-Uk Kim, M.D., Ph.D. |
|
J Rheum Dis 2022; 29(2): 98-107
|
|
|
|
|
| Case Reports |
|
|
|
A Case of Macrophage Activation Syndrome During the Treatment of Adult-onset Still’s Disease With Tocilizumab |
| Ju Ho Lee, M.D., You-Jung Ha, M.D., Ph.D., Eun Ha Kang, M.D., Ph.D., Sung Hae Chang, M.D., Yun Jong Lee, M.D., Ph.D. |
|
J Rheum Dis 2022; 29(2): 123-128
|
|
.jpg?2205280129)
J Rheum Dis 2022; 29(2): 59~128